Detalhe da pesquisa
1.
Cost-effectiveness of pharmacogenomic-guided treatment for major depression.
CMAJ
; 195(44): E1499-E1508, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963621
2.
Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
Can J Psychiatry
; 68(6): 436-452, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437757
3.
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol.
Pharmacoecon Open
; 8(3): 493-505, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38528312
4.
Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience.
Pharmacoeconomics
; 40(10): 971-977, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877043